London: The AstraZeneca-Oxford vaccine will be tested on children in the first test by a major manufacturer on young people, University of Oxford has confirmed.

Published 6 years ago on Feb 15th 2021, 3:12 am
By Web Desk
The trial will test safety of the vaccine as well as immune system response generated by it in children aged between 6 and 17 years.
300 children will be enrolled in the trial which will take place in London, Southampton and Bristol. The trial will begin by February end, the university said in a statement.
Coronavirus has relatively been less harmful in children with milder cases as compared to adults and less contagion potential, although the jury is still out on that aspect of the virus.

The case for data centers, explained by a person who wants you to like them
- 19 hours ago

AMD is bringing FSR 4.1 to Xbox consoles and handhelds
- 21 hours ago

Some Google Home Speakers caught downloading hundreds of gigs of data
- 21 hours ago

Major European mobile carriers are teaming up for a ‘direct’ satellite program without Starlink
- 21 hours ago

This chart shows just how rapidly Ebola is spreading
- 19 hours ago

PM calls for promoting Pak-Maldives trade, investment ties
- an hour ago

Brook scores fastest double century in ODI history in rampant England's 429-4
- 7 hours ago

Trump is coming for your credit card rewards. That’s good.
- 19 hours ago

Pakistan, EU agree to cement counterterrorism cooperation
- 7 hours ago

Two killed, 8 injured in attack on airport in Saudi oil city Dammam
- 10 hours ago

Why your health insurance is dropping GLP-1 coverage
- 19 hours ago

The French youth revolt
- 19 hours ago
You May Like
Trending














